[HTML][HTML] Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors
Z Lu, TSS Wientjes, JLS Au - Pharmaceutical research, 2005 - Springer
Purpose We reported that nontoxic suramin treatments enhance the activity of chemotherapy
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
Nontoxic Suramin Treatments Enhance Docetaxel Activity in Chemotherapy-Pretreated Non-Small Cell Lung Xenograft Tumors
Z Lu, TSS Wientjes, JLS Au - Pharmaceutical Research, 2005 - infona.pl
Purpose We reported that nontoxic suramin treatments enhance the activity of chemotherapy
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors
Z Lu, TSS Wientjes, JLS Au - Pharmaceutical research, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose We reported that nontoxic suramin treatments enhance the activity of chemotherapy
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
[PDF][PDF] Nontoxic Suramin Treatments Enhance Docetaxel Activity in Chemotherapy-Pretreated Non-Small Cell Lung Xenograft Tumors
Z Lu, TSS Wientjes, JLS Au - Pharmaceutical Research, 2005 - researchgate.net
Purpose. We reported that nontoxic suramin treatments enhance the activity of
chemotherapy in preclinical models, a finding supported by the results of subsequent phase …
chemotherapy in preclinical models, a finding supported by the results of subsequent phase …
Nontoxic Suramin Treatments Enhance Docetaxel Activity in Chemotherapy-Pretreated Non-Small Cell Lung Xenograft Tumors
Z Lu, TSS Wientjes, JLS Au - Pharmaceutical Research, 2005 - search.proquest.com
We reported that nontoxic suramin treatments enhance the activity of chemotherapy in
preclinical models, a finding supported by the results of subsequent phase I/II trials in …
preclinical models, a finding supported by the results of subsequent phase I/II trials in …
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Z Lu, TS Wientjes, JL Au - Pharmaceutical Research, 2005 - europepmc.org
Purpose We reported that nontoxic suramin treatments enhance the activity of chemotherapy
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …
in preclinical models, a finding supported by the results of subsequent phase I/II trials in …